392 Shares in McKesson Co. (NYSE:MCK) Acquired by Lingohr Asset Management GmbH

Lingohr Asset Management GmbH bought a new stake in shares of McKesson Co. (NYSE:MCK - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 392 shares of the company's stock, valued at approximately $224,000.

A number of other hedge funds have also recently made changes to their positions in MCK. Cibc World Market Inc. boosted its position in McKesson by 6.3% in the 4th quarter. Cibc World Market Inc. now owns 20,252 shares of the company's stock valued at $11,542,000 after buying an additional 1,207 shares during the period. Commerce Bank grew its stake in McKesson by 2.0% in the third quarter. Commerce Bank now owns 156,781 shares of the company's stock worth $77,516,000 after purchasing an additional 3,020 shares in the last quarter. West Oak Capital LLC increased its holdings in McKesson by 867.7% during the 4th quarter. West Oak Capital LLC now owns 3,000 shares of the company's stock worth $1,710,000 after purchasing an additional 2,690 shares during the period. Brentview Investment Management LLC bought a new stake in McKesson during the 4th quarter valued at $3,018,000. Finally, Ingalls & Snyder LLC lifted its holdings in shares of McKesson by 8.2% in the 4th quarter. Ingalls & Snyder LLC now owns 13,824 shares of the company's stock worth $7,878,000 after buying an additional 1,047 shares during the period. 85.07% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on MCK. Citigroup decreased their price objective on McKesson from $713.00 to $677.00 and set a "buy" rating for the company in a report on Friday, January 10th. Mizuho initiated coverage on shares of McKesson in a report on Wednesday, December 4th. They issued a "neutral" rating and a $630.00 target price for the company. Evercore ISI raised their price target on shares of McKesson from $650.00 to $675.00 and gave the company an "outperform" rating in a report on Thursday, February 6th. Morgan Stanley increased their price objective on McKesson from $612.00 to $642.00 and gave the company an "overweight" rating in a report on Tuesday, December 17th. Finally, StockNews.com lowered McKesson from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 14th. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, McKesson has a consensus rating of "Moderate Buy" and a consensus price target of $649.36.

Remove Ads

McKesson Trading Up 0.1 %

MCK traded up $0.39 during midday trading on Monday, hitting $661.56. 775,431 shares of the company were exchanged, compared to its average volume of 800,762. The firm has a market capitalization of $82.91 billion, a price-to-earnings ratio of 30.29, a price-to-earnings-growth ratio of 1.29 and a beta of 0.52. The company's 50 day simple moving average is $617.68 and its 200 day simple moving average is $575.39. McKesson Co. has a 1-year low of $464.42 and a 1-year high of $673.23.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. On average, equities analysts anticipate that McKesson Co. will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.43%. The ex-dividend date is Monday, March 3rd. McKesson's dividend payout ratio (DPR) is presently 13.00%.

Insider Buying and Selling at McKesson

In related news, EVP Leann B. Smith sold 188 shares of the company's stock in a transaction dated Wednesday, February 12th. The shares were sold at an average price of $609.59, for a total transaction of $114,602.92. Following the completion of the transaction, the executive vice president now owns 1,051 shares in the company, valued at $640,679.09. This represents a 15.17 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Brian S. Tyler sold 8,961 shares of the business's stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $597.99, for a total value of $5,358,588.39. Following the sale, the chief executive officer now owns 60,664 shares of the company's stock, valued at approximately $36,276,465.36. This trade represents a 12.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 18,689 shares of company stock valued at $11,187,351. Company insiders own 0.11% of the company's stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.